BCE Inc.:戦略・SWOT・企業財務分析

◆英語タイトル:BCE Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015613
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:通信・IT
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

BCE Inc. – Strategy, SWOT and Corporate Finance Report
Summary

BCE Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

BCE Inc. (BCE or “the company”) is a communications company, providing a range of solutions including wireless voice and data, internet access, internet protocol television (IPTV), local and long distance telephone, satellite television (TV), business internet protocol (IP), conventional, specialty and pay TV, digital media, radio broadcasting and out of home (OOH) advertising services to residential, business and wholesale customers. The company operates primarily in Canada where it is headquartered in Quebec and employed 49,968 people as on December 31, 2015.

Scope

- Detailed information on BCE Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BCE Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BCE Inc. including a breakdown and examination of key business segments
- Intelligence on BCE Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BCE Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of BCE Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess BCE Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on BCE Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
BCE Inc.: Company Overview
BCE Inc.: Overview and Key Facts
BCE Inc.: Overview
BCE Inc.: Key Facts
BCE Inc.: Key Employees
BCE Inc.: Key Employee Biographies
BCE Inc.: Major Products and Services
BCE Inc.: Company History
BCE Inc.: Management Statement
BCE Inc.: Locations and Subsidiaries
BCE Inc.: Key Competitors
BCE Inc.: Company Analysis
BCE Inc.: Business Description
BCE Inc.: SWOT Analysis
BCE Inc.: SWOT Overview
BCE Inc.: Strengths
BCE Inc.: Weaknesses
BCE Inc.: Opportunities
BCE Inc.: Threats
BCE Inc.: Corporate Financial Deals Activity
BCE Inc.: Financial Deals Overview
BCE Inc.: Targets and Partners
BCE Inc.: Top Deals 2013 – 2017YTD*
BCE Inc.: Advisors
BCE Inc.: Top Financial Advisors
BCE Inc.: Mergers and Acquisitions
BCE Inc.: Partnership
BCE Inc.: Divestments
BCE Inc.: Recent Developments
BCE Inc.: News and Events Summary
BCE Inc.: Business Expansion
BCE Inc.: Contracts
BCE Inc.: Financial Deals
BCE Inc.: Financial Performance
BCE Inc.: Research & Development
BCE Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: BCE Inc.: Key Facts
Table 2: BCE Inc.: Key Employees
Table 3: BCE Inc.: Locations and Subsidiaries
Table 4: BCE Inc.: Key Competitors
Table 5: BCE Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: BCE Inc.: M&A Activity by Geography (TTM*)
Table 7: BCE Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: BCE Inc.: M&A Average Deal Size - Value (US$m)
Table 9: BCE Inc.: Targets and Partners
Table 10: BCE Inc.: Top Deals 2013 - 2017YTD*
Table 11: BCE Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: BCE Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 13: BCE Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 14: BCE Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 15: BCE Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 16: BCE Inc.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 17: BCE Inc.: Divestments by Geography (2013 - YTD*2017)
Table 18: BCE Inc.: News and Events Summary
Table 19: BCE Inc.: Business Expansion
Table 20: BCE Inc.: Contracts
Table 21: BCE Inc.: Financial Deals
Table 22: BCE Inc.: Financial Performance
Table 23: BCE Inc.: Research & Development
Table 24: BCE Inc.: Strategy and Operations

★海外企業調査レポート[BCE Inc.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oaktree Capital Group Llc
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Inform Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Inform Diagnostics Inc(Inform Diagnostics) formerly known as Miraca Life Sciences, a subsidiary of Miraca Holdings Inc, is an anatomic pathology laboratory that offers diagnostic services. The laboratory provides services in the areas of breast health, dermatology, gastroenterology, hematolo …
  • Reliance Infrastructure Ltd.:企業の戦略・SWOT・財務情報
    Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report Summary Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • OncoMed Pharmaceuticals Inc (OMED):企業の財務・戦略的SWOT分析
    Summary OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TI …
  • Herman Miller, Inc.:企業の戦略・SWOT・財務情報
    Herman Miller, Inc. - Strategy, SWOT and Corporate Finance Report Summary Herman Miller, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SSY Group Ltd (2005):企業の財務・戦略的SWOT分析
    Summary SSY Group Ltd (SSY), formerly Lijun International Pharmaceutical (Holding) Co Ltd is a pharmaceutical company that offers range of pharmaceutical products such as intravenous infusion solution. The company offers glass bottle infusion solutions, non-PVC soft bag infusions, and PP plastic bot …
  • Fresenius Kabi AG:企業の戦略的SWOT分析
    Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Celonic AG-製薬・医療分野:企業M&A・提携分析
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that provides contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of ac …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務情報
    The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report Summary The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Qurient Co Ltd (115180):製薬・医療:M&Aディール及び事業提携情報
    Summary Qurient Co Ltd (Qurient) is a pharmaceutical company that offers development of new drugs for unmet medical needs. The company provides portfolio of pipeline products such as Q301, Q203, Q701, 5LO INH and CDK7 INH, among others. It is developing products for the treatment of atopic dermatiti …
  • Zygo Corporation:企業の戦略的SWOT分析
    Zygo Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Nascent Biotech Inc (NBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Nascent Biotech Inc (Nascent) is a clinical-stage biopharmaceutical company. The company delivers human monoclonal antibodies and cytokine for the treatment of cancer and drug discovery platform for identifying new antibodies and antigens for commercialization. It develops Pritumumab, a mono …
  • DEPObank – Banca Depositaria Italiana SpA:企業の戦略的SWOT分析
    DEPObank - Banca Depositaria Italiana SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Sebia SA:医療機器:M&Aディール及び事業提携情報
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • Consolidated Edison, Inc.:企業の戦略・SWOT・財務分析
    Consolidated Edison, Inc. - Strategy, SWOT and Corporate Finance Report Summary Consolidated Edison, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Amgen Inc (AMGN)-製薬・医療分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Dohler GmbH:戦略・SWOT・企業財務分析
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sonoro Energy Ltd (SNV):企業の財務・戦略的SWOT分析
    Summary Sonoro Energy Ltd (Sonoro Energy), formerly Sonic Technology Solutions Inc is an oil and gas company that explores, develops and produces asphalt and bitumen resources. It operates Budong Budong Production Sharing Contract on the coast of western Sulawesi, opposite to Balikpapan that offers …
  • Odonate Therapeutics Inc (ODT):製薬・医療:M&Aディール及び事業提携情報
    Summary Odonate Therapeutics Inc (Odonate), formerly Odonate Therapeutics LLC, is a pharmaceutical company that develops medicines for the treatment of cancer. The company provides product candidate, tesetaxel which is a novel orally administered taxane used for the treatment of advanced and metasta …
  • Chimerix Inc (CMRX):企業の財務・戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a bio pharmaceutical company that develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s brincidofovir, an oral nucleotide analog to treat dsDNA viruses, adenovirus, cytomegalovirus, BK virus and herpes simplex viruses. Chimeri …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆